Research Articles | Page 4 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Unrelated Hematopoietic Cell Transplantation in Aplastic Anemia: There Is More to a Successful Outcome Than Meets the Eye May 2015 JAMA Oncol aplastic anemia
Unrelated cord blood transplantation in a child with very severe aplastic anemia Dec 2012 Rinsho Ketsueki aplastic anemia
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions Jan 2016 Curr Oncol Rep myelodysplastic syndromes (MDS)
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia May 2018 Biol Blood Marrow Transplant acute myeloid leukemia (AML)
Under-recognition of Platelet dysfunction in Myelodysplastic Syndromes: are we only seeing the tip of the iceberg? Aug 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes. Jan 2019 Leuk Lymphoma. myelodysplastic syndromes (MDS)
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure Dec 2016 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Treatment options for lower-risk myelodysplastic syndromes. Where are we now? Jan 2021 Therapeutic Advances in Hematology myelodysplastic syndromes (MDS)
Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT). Jan 2014 Curr Hematol Malig Rep myelodysplastic syndromes (MDS)
Treatment of low-risk myelodysplastic syndromes Dec 2016 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Share with addtoany.com.